Drug · DIN 02277263
VESICARE
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since June 23, 2006; first marketed June 23, 2006.
- Drug Identification Number (DIN)
- 02277263
- Company (DIN owner)
- Astellas Pharma Canada IncMarkham, Ontario, Canada
- Schedule
- Prescription
- Dosage form
- Tablet
- Route
- Oral
- Therapeutic class (ATC)
- Solifenacin G04BD08
- Class
- Human
- Record last updated
- March 22, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| SOLIFENACIN SUCCINATE | 5 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- February 20, 2006: NOC 7774New Drug Submission (NDS)
Other DINs named VESICARE
- DIN 02277271 · Marketed